Literature DB >> 26938862

Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.

Hongzhao Qi1, Chaoyong Liu2, Lixia Long1, Yu Ren3, Shanshan Zhang1, Xiaodan Chang1, Xiaomin Qian1, Huanhuan Jia3, Jin Zhao1, Jinjin Sun4, Xin Hou1, Xubo Yuan1, Chunsheng Kang2.   

Abstract

Exosomes are a class of naturally occurring nanoparticles that are secreted endogenously by mammalian cells. Clinical applications for exosomes remain a challenge because of their unsuitable donors, low scalability, and insufficient targeting ability. In this study, we developed a dual-functional exosome-based superparamagnetic nanoparticle cluster as a targeted drug delivery vehicle for cancer therapy. The resulting exosome-based drug delivery vehicle exhibits superparamagnetic behavior at room temperature, with a stronger response to an external magnetic field than individual superparamagnetic nanoparticles. These properties enable exosomes to be separated from the blood and to target diseased cells. In vivo studies using murine hepatoma 22 subcutaneous cancer cells showed that drug-loaded exosome-based vehicle delivery enhanced cancer targeting under an external magnetic field and suppressed tumor growth. Our developments overcome major barriers to the utility of exosomes for cancer application.

Entities:  

Keywords:  cancer targeting; drug delivery; exosome; scalable separation; superparamagnetic nanoparticle clusters

Mesh:

Substances:

Year:  2016        PMID: 26938862     DOI: 10.1021/acsnano.5b06939

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  114 in total

1.  Aptamer-Functionalized Exosomes: Elucidating the Cellular Uptake Mechanism and the Potential for Cancer-Targeted Chemotherapy.

Authors:  Jianmei Zou; Muling Shi; Xiaojing Liu; Cheng Jin; Xiaojing Xing; Liping Qiu; Weihong Tan
Journal:  Anal Chem       Date:  2019-01-24       Impact factor: 6.986

Review 2.  Engineering exosomes: a new direction for anticancer treatment.

Authors:  Benshuai You; Wenrong Xu; Bin Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 3.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

Review 4.  Photothermal therapies to improve immune checkpoint blockade for cancer.

Authors:  Preethi B Balakrishnan; Elizabeth E Sweeney; Anvitha S Ramanujam; Rohan Fernandes
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

5.  Exosomes Secreted by the Cocultures of Normal and Oxygen-Glucose-Deprived Stem Cells Improve Post-stroke Outcome.

Authors:  Koteswara Rao Nalamolu; Ishwarya Venkatesh; Adithya Mohandass; Jeffrey D Klopfenstein; David M Pinson; David Z Wang; Adinarayana Kunamneni; Krishna Kumar Veeravalli
Journal:  Neuromolecular Med       Date:  2019-05-10       Impact factor: 3.843

Review 6.  The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].

Authors:  Vignesh Sundararajan; Fazlul H Sarkar; Thamil Selvee Ramasamy
Journal:  Cell Oncol (Dordr)       Date:  2018-04-17       Impact factor: 6.730

Review 7.  Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics.

Authors:  Qingfu Zhu; Mikala Heon; Zheng Zhao; Mei He
Journal:  Lab Chip       Date:  2018-06-12       Impact factor: 6.799

8.  Engineering Extracellular Vesicles for Cancer Therapy.

Authors:  Christina Nedeva; Suresh Mathivanan
Journal:  Subcell Biochem       Date:  2021

9.  Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery.

Authors:  Yuan Wan; Lixue Wang; Chuandong Zhu; Qin Zheng; Guoxiang Wang; Jinlong Tong; Yuan Fang; Yiqiu Xia; Gong Cheng; Xia He; Si-Yang Zheng
Journal:  Cancer Res       Date:  2017-12-07       Impact factor: 12.701

Review 10.  Exosomes in Prostate Cancer Diagnosis, Prognosis and Therapy.

Authors:  Tomasz Lorenc; Katarzyna Klimczyk; Izabela Michalczewska; Monika Słomka; Grażyna Kubiak-Tomaszewska; Wioletta Olejarz
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.